eBook: T Cell-Based Therapies
The in vivo performance of cell therapies will improve with deeper understanding of cellular behavior, while technological advances contribute to process efficiency, scalability, and safety. In this eBook, we outline several biological and manufacturing challenges for T cell therapies and highlight how our solutions can help overcome these obstacles at each process stage.
Whether you are at the earliest phase of discovery, looking to move your program into the clinic, or progressing rapidly towards commercialization, there’s undoubtedly a solution for you. From ancillary materials to automated analytical tools, we are committed to delivering innovative solutions that enable cell and gene therapies to reach more patients.
Download your copy of this eBook to learn about:
Biological Challenges
- T Cell Exhaustion
- Checkpoint Blockade
- Immunosuppressive TME
- Cell Migration
- Tumor Heterogeneity
- Monitoring Efficacy and Toxicity
- T Cell Subsets and Capabilities
Manufacturing Challenges
- Scaling Up
- Cell Characterization
- Customization
- Outsourcing and CDMO
- Raw Materials Qualification
- Transition to GMP
- Quality
Process Stages
- Isolating T Cell Populations
- Cell Activation and Expansion
- Cell Engineering
- Cell Characterization
- Monitoring Efficacy and Toxicity
